Akebia Therapeutics, Inc. (AKBA) Social Stream
AKEBIA THERAPEUTICS INC (AKBA) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering AKBA.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-05 | 4 | $8 | $2.75 | $5.937 | $1.48 | 301.15% |
| 2022-01-28 | 2 | $10 | $6 | $8 | $1.48 | 440.54% |
| 2022-03-02 | 3 | $10 | $6 | $8 | $1.48 | 440.54% |
| 2022-03-08 | 4 | $10 | $6 | $8 | $1.48 | 440.54% |
| 2022-03-31 | 7 | $2 | $2 | $2 | $1.48 | 35.14% |
| 2022-05-10 | 7 | $2 | $1 | $1.75 | $1.48 | 18.24% |
| 2022-05-16 | 6 | $2 | $1.25 | $1.75 | $1.48 | 18.24% |
| 2022-06-06 | 7 | $2 | $1 | $1.562 | $1.48 | 5.54% |
| 2023-03-10 | 5 | $2 | $1.25 | $1.75 | $1.48 | 18.24% |
| 2023-04-26 | 2 | $2 | $2 | $2 | $1.48 | 35.14% |
| 2023-05-26 | 3 | $2 | $2 | $2 | $1.48 | 35.14% |
| 2023-07-24 | 3 | $4 | $2 | $3 | $1.48 | 102.7% |
| 2023-08-25 | 3 | $4 | $2 | $3 | $1.48 | 102.7% |
| 2023-11-09 | 3 | $4 | $3.75 | $3.875 | $1.48 | 161.82% |
| 2023-11-17 | 3 | $5 | $4 | $4.5 | $1.48 | 204.05% |
| 2023-11-29 | 4 | $5 | $4 | $4.333 | $1.48 | 192.77% |
The Trend in the Analyst Price Target
AKBA's average price target has moved down $12.79 over the prior 43 months.
AKBA reports an average of 188.93% for its upside potential over the past 38 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-10 | 2 | 2 | 1.25 | 1.625 | 0.799 | 103.38% |
| 2023-08-25 | 3 | 4 | 2.00 | 3.000 | 1.150 | 160.87% |
| 2023-11-09 | 3 | 4 | 3.75 | 3.875 | 0.910 | 325.82% |
| 2023-11-17 | 3 | 5 | 4.00 | 4.500 | 1.000 | 350% |
| 2023-11-29 | 4 | 5 | 4.00 | 4.333 | 1.000 | 333.3% |
AKBA Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.5 | 3 | 0 | 1 | 0 | 0 | 4 |
The Trend in the Broker Recommendations
AKBA's average broker recommendation rating improved by 1.33 over the prior 15 months.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In the context of all US stocks, AKEBIA THERAPEUTICS INC's average analyst price target is higher than 45.14% of them.
- In terms of how AKEBIA THERAPEUTICS INC fares relative to all US stocks, note that its number of analysts covering the stock is greater than 257.53% of that group.
- In the context of Pharmaceutical Products stocks, AKEBIA THERAPEUTICS INC's variance in analysts' estimates is lower than -337.21% of them.
- To contextualize these metrics, consider that out of stocks in the small market cap category, AKEBIA THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is higher than 810.26% of them.
In the Pharmaceutical Products industry, EGRX, CPRX, and LXRX are the three stocks most similar to AKEBIA THERAPEUTICS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is AKBA a Buy, Hold or Sell? See the POWR Ratings now!